{
    "clinical_study": {
        "@rank": "146248", 
        "arm_group": [
            {
                "arm_group_label": "Anplag", 
                "arm_group_type": "Active Comparator", 
                "description": "Sarpogrelate HCl 300mg once a day or 100mg three times a day"
            }, 
            {
                "arm_group_label": "UI03SPG300CT", 
                "arm_group_type": "Experimental", 
                "description": "Sarpogrelate HCl 300mg once a day or 100mg three times a day"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the pharmacokinetics of sarpogrelate\n      controlled-release formulation (CR) in comparison to immediate-release formulation (IR) and\n      Food effect on the pharmacokinetics of sarpogrelate CR."
        }, 
        "brief_title": "Pharmacokinetics and Food Effect of Sarpogrelate HCl CR Formulation in Comparison to Immediate-release Formulation", 
        "completion_date": {
            "#text": "December 2011", 
            "@type": "Actual"
        }, 
        "condition": "Healthy", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  20 to 55 years of healthy volunteers\n\n        Exclusion Criteria:\n\n          -  Hypersensitivity Reaction about Sarpogrelate HCl or other antiplatelets"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "55 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 21, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01841086", 
            "org_study_id": "KUP-SPG3-101"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Anplag", 
                    "UI03SPG300CT"
                ], 
                "description": "Sarpogrelate HCl 300mg once a day or 100mg three times a day", 
                "intervention_name": "Anplag", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Anplag", 
                    "UI03SPG300CT"
                ]
            }, 
            {
                "arm_group_label": [
                    "Anplag", 
                    "UI03SPG300CT"
                ], 
                "description": "Sarpogrelate HCl 300mg once a day or 100mg three times a day", 
                "intervention_name": "UI03SPG300CT", 
                "intervention_type": "Drug", 
                "other_name": "UI03SPG300CT"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Sarpogrelate"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 23, 2013", 
        "number_of_arms": "2", 
        "official_title": "A Randomized, Open-label, Single Dose, 3-Treatment, 3-Period Williams-Design to Assess the Pharmacokinetic Characteristics and Food Effect of Sarpogrelate HCl CR Tablets Compared With Sarpogrelate HCl IR Tablets in Healthy Male Subjects", 
        "overall_official": {
            "affiliation": "Samsung Medical Center", 
            "last_name": "Wooseong Huh, M.D., Ph.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "South Korea: Korea Food and Drug Administration (KFDA)"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "November 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "Active Comparator : predose(0), 0.25, 0.5, 1, 1.5, 2, 3, 6(immediately before 2nd drug intake) , 6.25, 6.5, 7, 7.5, 8, 9, 12(immediately before 3rd drug intake), 12.5, 13, 13.5, 14, 15, 16, 24 hours post-dose Experimental : predose(0), 0.25, 0.5, 1, 1.5, 2, 2.5, 3, 4, 5, 6, 8, 12, 16, 24 hours post-dose", 
                "measure": "Cmax", 
                "safety_issue": "No", 
                "time_frame": "24h"
            }, 
            {
                "description": "Active Comparator : predose(0), 0.25, 0.5, 1, 1.5, 2, 3, 6(immediately before 2nd drug intake) , 6.25, 6.5, 7, 7.5, 8, 9,12(immediately before 3rd drug intake), 12.5, 13, 13.5, 14, 15, 16, 24 hours post-dose Experimental : predose(0), 0.25, 0.5, 1, 1.5, 2, 2.5, 3, 4, 5, 6, 8, 12, 16, 24 hours post-dose", 
                "measure": "AUCt", 
                "safety_issue": "No", 
                "time_frame": "24h"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01841086"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Active Comparator : predose(0), 0.25, 0.5, 1, 1.5, 2, 3, 6(immediately before 2nd drug intake) , 6.25, 6.5, 7, 7.5, 8, 9, 12(immediately before 3rd drug intake), 12.5, 13, 13.5, 14, 15, 16, 24 hours post-dose Experimental : predose(0), 0.25, 0.5, 1, 1.5, 2, 2.5, 3, 4, 5, 6, 8, 12, 16, 24 hours post-dose", 
                "measure": "tmax, t1/2", 
                "safety_issue": "No", 
                "time_frame": "24h"
            }, 
            {
                "description": "Active Comparator : predose(0), 0.25, 0.5, 1, 1.5, 2, 3, 6(immediately before 2nd drug intake) , 6.25, 6.5, 7, 7.5, 8, 9,12(immediately before 3rd drug intake), 12.5, 13, 13.5, 14, 15, 16, 24 hours post-dose Experimental : predose(0), 0.25, 0.5, 1, 1.5, 2, 2.5, 3, 4, 5, 6, 8, 12, 16, 24 hours post-dose", 
                "measure": "AUC0-\u221e", 
                "safety_issue": "No", 
                "time_frame": "24h"
            }
        ], 
        "source": "Korea United Pharm. Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Korea United Pharm. Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2013"
    }
}